Pharmaxis (ASX:PXS)
Company Profile
Pharmaxis (ASX:PXS) has changed its name to Syntara – SNT (ASX: SNT).
Below are the previous articles from Pharmaxis (ASX:PXS):
RELATED STOCKHEAD STORIES
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Move over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalysts
ScoPo’s Powerplays: ASX health stocks fall but don’t throw the baby out with the bathwater
ASX Health Stocks: Cannabis stock Little Green Pharma awarded French trial tender for CBD50
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
CLOSING BELL: A crazy ride for tech stocks and Wildcat as the ASX dips 0.22%
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
ASX Health Stocks: Pharmaxis and Aroa lift on FDA news, Cynata to commence Phase 2 trial
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
